Pathway

Statins May Lower Cancer Risk by Blocking Chronic Inflammation Pathway: New Study Reveals

by

Boston, Massachusetts – A recent study suggests that the use of common cholesterol-lowering drugs, known as statins, may potentially reduce the risk of cancer development. The research conducted by the Mass General Cancer Center found that statins could target a pathway involved in cancer formation due to chronic inflammation in the body. Dr. Shawn Demehri, the senior author of the study, highlighted the significance of chronic inflammation as a leading cause of cancer globally. The …

Read more

Reward Pathway in Brain Hijacked by Drugs, Overrides Basic Needs – Scientists Uncover Groundbreaking Discovery

by

New York, NY – Scientists in New York have made a groundbreaking discovery that sheds light on how addictive drugs like cocaine and morphine can override our natural instincts for essential needs such as food and water. This finding could pave the way for innovative treatment strategies to combat addiction. Researchers from Rockefeller University and the Icahn School of Medicine at Mount Sinai utilized mouse models to investigate how cocaine and morphine affect the brain’s …

Read more

**Attention** “Unlocking the Power of Attention: Groundbreaking Study Reveals Brain’s Pathway from Visual Processing to Action”

by

PARIS, France – Researchers at the Paris Brain Institute have made significant strides in understanding the brain’s mechanisms of attention through the use of depth electrodes in epilepsy patients. By studying exogenous attention, the involuntary shift of focus triggered by external stimuli, researchers were able to capture neural activity across 1,400 brain regions. This approach revealed a continuum of cortical networks involved in the development of attention from visual processing to action response. The study …

Read more

Cardiovascular Disease Risk: Niacin’s Role in Fueling Inflammation in New Pathway Revealed by Cleveland Clinic Research

by

CLEVELAND, OHIO – A team of researchers from the Cleveland Clinic has made a groundbreaking discovery related to cardiovascular disease. Their study has found a new pathway that contributes to heart disease, linked to excess niacin, also known as vitamin B-3. The team, led by Dr. Stanley Hazen, identified a byproduct of excess niacin called 4PY, which has been found to be strongly associated with an increased risk of heart attack, stroke, and vascular inflammation. …

Read more